Position in URGN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,778,975
-$535,598 QoQ
Shares Held
98,942
+0.1% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,725,512 across 270 Biotechnology names. URGN ranks #135 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in URGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,778,975 | 98,942 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,314,573 | 98,829 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,902,291 | 95,353 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,279,989 | 93,430 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,033,998 | 93,490 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,001,067 | 93,997 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,112,100 | 87,567 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,621,265 | 96,619 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,023,285 | 68,219 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,051,560 | 70,104 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $809,860 | 57,806 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $475,271 | 45,920 | Shares | Defined | 2023-08-03 | |
| 2022-03-31 | $587,802 | 67,486 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $573,348 | 60,289 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,031,637 | 61,334 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $855,989 | 56,057 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,033,043 | 53,031 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $1,036,894 | 53,753 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,444,774 | 55,313 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $859,816 | 48,196 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||